SEC Form 4 · accession 0001437749-18-010500
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack B. Strommen
Director
Period of report
May 18, 2018
Accepted (ET)
May 22, 2018 · 2:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2018 | C | 2,201,714 | $0.30 | A | 4,308,012 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF2,F3,F4 | $0.30 | May 18, 2018 | C | — | D | Oct 8, 2015 | Jun 1, 2018 | Common Stock | 2,166,667 | — | I |
Explanation of responses
- F1Shares were issued to Reporting Person in exchange for conversion of the promissory note reported as "disposed" in Table II, issued in exchange for a $650,000 investment in Issuer's 2015 Unit Offering, and include shares issued as payment of principal at $0.30 per share and accrued interest at $0.25 per share.
- F2Represents the conversion price set forth in the Convertible Promissory Note reported herein.
- F3Reporting Person elected to reduce conversion price of subject promissory note from $0.35 to $0.30 through the payment of $39,000.
- F4Upon reduction of conversion price to $0.30, number of shares of common stock underlying the note increased from 1,857,143 to 2,166,667.